Covidien gets FDA nod for embolic protection device

The FDA has granted Covidien 510(k) clearance for its SpiderFX device, which is used in combination with plaque excision to treat severely calcified lesions in arteries found in the lower extremities. The device is the only embolic protection device cleared in the U.S. for lower extremity use, the company said in a release.

View Full Article in:

Mass High Tech (Boston) · Boston Globe (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC